7.60
-0.22(-2.81%)
Currency In USD
| Previous Close | 7.82 |
| Open | 7.64 |
| Day High | 7.78 |
| Day Low | 7.01 |
| 52-Week High | 10 |
| 52-Week Low | 2.54 |
| Volume | 939,740 |
| Average Volume | 849,964 |
| Market Cap | 567.31M |
| PE | -14.07 |
| EPS | -0.54 |
| Moving Average 50 Days | 6.84 |
| Moving Average 200 Days | 4.84 |
| Change | -0.22 |
If you invested $1000 in Corvus Pharmaceuticals, Inc. (CRVS) since IPO date, it would be worth $533.33 as of November 09, 2025 at a share price of $7.6. Whereas If you bought $1000 worth of Corvus Pharmaceuticals, Inc. (CRVS) shares 5 years ago, it would be worth $1,904.76 as of November 09, 2025 at a share price of $7.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
GlobeNewswire Inc.
Nov 03, 2025 2:02 PM GMT
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that final data from its Phase 1/1b trial of soquelitinib in patients with T cel
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
GlobeNewswire Inc.
Oct 31, 2025 11:30 AM GMT
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with invest
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2025 Financial Results on November 4, 2025
GlobeNewswire Inc.
Oct 28, 2025 8:01 PM GMT
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PTSOUTH SAN FRANCISCO, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the c